OPCs are resident progenitor cells distributed throughout the central nervous system. Their primary role is to differentiate into oligodendrocytes that ensheath axons with myelin during brain development and remyelinate axons after brain damage. Myelination is a complex biological process involving axon recognition and attachment, membrane wrapping and compaction, and myelin maintenance 1,2 . It is generally assumed that these tasks are accomplished by OPCs rather than by mature oligodendrocytes because transplantation studies in animal models have found that grafted OPCs readily myelinate whereas mature oligodendrocytes do not 2 . Therefore, OPCs have been identified as a promising cell population for therapeutic approaches in both dysmyelinating and demyelinating diseases. In particular, genetic diseases affecting myelin, such as PelizaeusMerzbacher disease and other familial leukodystrophies, would be ideal candidates for cell-based therapies 3 . In addition, more prevalent conditions, such as spinal cord injury and multiple sclerosis, could benefit from OPC transplantation 2,4,5 . Notably, OPCs derived from the fetal brain or embryonic stem (ES) cells have been shown to remyelinate axons in rodent models of myelin diseases, in some cases with impressive therapeutic benefits 6-11 . Unfortunately, primary human tissue is limited, and ES cell differentiation is slow and tedious [11] [12] [13] . We therefore sought to determine whether OPCs can be generated by direct lineage conversion from readily available somatic lineages such as fibroblasts.
A r t i c l e s
OPCs are resident progenitor cells distributed throughout the central nervous system. Their primary role is to differentiate into oligodendrocytes that ensheath axons with myelin during brain development and remyelinate axons after brain damage. Myelination is a complex biological process involving axon recognition and attachment, membrane wrapping and compaction, and myelin maintenance 1, 2 . It is generally assumed that these tasks are accomplished by OPCs rather than by mature oligodendrocytes because transplantation studies in animal models have found that grafted OPCs readily myelinate whereas mature oligodendrocytes do not 2 . Therefore, OPCs have been identified as a promising cell population for therapeutic approaches in both dysmyelinating and demyelinating diseases. In particular, genetic diseases affecting myelin, such as PelizaeusMerzbacher disease and other familial leukodystrophies, would be ideal candidates for cell-based therapies 3 . In addition, more prevalent conditions, such as spinal cord injury and multiple sclerosis, could benefit from OPC transplantation 2, 4, 5 . Notably, OPCs derived from the fetal brain or embryonic stem (ES) cells have been shown to remyelinate axons in rodent models of myelin diseases, in some cases with impressive therapeutic benefits [6] [7] [8] [9] [10] [11] . Unfortunately, primary human tissue is limited, and ES cell differentiation is slow and tedious [11] [12] [13] . We therefore sought to determine whether OPCs can be generated by direct lineage conversion from readily available somatic lineages such as fibroblasts.
Previously, we identified transcription factor combinations that mediate the rapid and efficient conversion of mouse fibroblasts directly into fully functional neuronal cells, which we called induced neuronal (iN) cells 14 . We and others further demonstrated the generation of iN cells from human fibroblasts 15 ; a combination of our standard iN cell factors with additional subtype-specific factors allowed the generation of neuronal subtypes, such as dopamine and motor neurons [16] [17] [18] ; and, more recently, tripotent neural precursor cells were induced from mouse fibroblasts [19] [20] [21] [22] [23] [24] .
Here we show that transcription factor-mediated reprogramming can also be applied to generate OPC-like cells. We found that forced expression of the three factors Sox10, Olig2 and Zfp536 converts rodent fibroblasts into iOPCs that express appropriate OPC markers, proliferate in OPC media conditions, differentiate into oligodendrocytes in vitro and myelinate host axons after transplantation into the dysmyelinated shiverer mouse brain.
RESULTS

A screen for OPC reprogramming factors
To identify candidate OPC reprogramming factors, we used data from detailed genome-wide expression studies and filtered the genes for transcription factors with greater expression in oligodendroglia compared to other neural lineages 25, 26 . We selected ten factors that participate in various stages of OPC specification and cause severe developmental oligodendroglia-related defects when mutated: Ascl1, Gm98, Myt1, Nkx2.2, Nkx6.1, Nkx6.2, Olig1, Olig2, Sox10 and Zfp536. We used a well-characterized proteolipid protein (Plp)-EGFP transgenic mouse strain, which expresses EGFP in both OPCs and mature oligodendrocytes, as a reporter for the presence of oligodendrocytic cells 27 . Mouse embryonic fibroblast (MEF) cultures were isolated from embryonic day 14.5 (E14.5) embryonic limbs, a tissue source that we had previously shown to yield a fibroblast population essentially devoid of cells expressing markers of neurons, neural progenitors and neural crest stem cells 14 (Fig. 1a) . The Plp-EGFP MEFs were transduced with a pool of ten different lentiviruses containing the candidate genes and cultured in media known
Generation of oligodendroglial cells by direct lineage conversion
Transplantation of oligodendrocyte precursor cells (OPCs) is a promising potential therapeutic strategy for diseases affecting myelin. However, the derivation of engraftable OPCs from human pluripotent stem cells has proven difficult and primary OPCs are not readily available. Here we report the generation of induced OPCs (iOPCs) by direct lineage conversion. Forced expression of the three transcription factors Sox10, Olig2 and Zfp536 was sufficient to reprogram mouse and rat fibroblasts into iOPCs with morphologies and gene expression signatures resembling primary OPCs. More importantly, iOPCs gave rise to mature oligodendrocytes that could ensheath multiple host axons when co-cultured with primary dorsal root ganglion cells and formed myelin after transplantation into shiverer mice. We propose direct lineage reprogramming as a viable alternative approach for the generation of OPCs for use in disease modeling and regenerative medicine.
to support OPC proliferation. No EGFP expression was detected in cultures not infected or infected with control viruses, based on fluorescence-microscopy or flow-cytometry analysis. In contrast, ~7 d after introducing the ten factors, a small number of EGFP + cells appeared in the cultures. After another 14 d, cells were fixed and analyzed by immunofluorescence with O4 antibodies, known to specifically mark oligodendrocytes as well as late-stage OPCs. This revealed the presence of Plp-EGFP + /O4 + cells with morphologies typical of oligodendrocytes ( Fig. 1b and Supplementary Fig. 1 ). Thus, some combinations of the ten candidate factors induced oligodendroglial properties in a fraction of the infected cells.
To identify the minimal number of required transcription factors for reprogramming toward the oligodendroglial lineage, we first determined whether any single factor was sufficient to generate EGFP + cells. Among the ten candidates, only Sox10 could activate the Plp-EGFP reporter, albeit in only a small fraction of infected cells (Fig. 1b) . We then tested the reprogramming activity of Sox10 in combination with each of the remaining nine candidate factors. Four factors (Nkx2.2, Nkx6.1, Olig2 and Zfp536) substantially increased the activity of Sox10 to generate EGFP + cells (Fig. 1c) . In a comprehensive process of systematic elimination, we determined that a combination of Sox10, Olig2 and Zfp536 was the minimal pool of factors sufficient to induce EGFP expression with the highest efficiency (Fig. 1d,e) . We independently repeated these experiments using fluorescenceactivated cell sorting (FACS) to determine the fraction of EGFP + cells after 1 week and observed similar results (Supplementary Fig. 2) . Thus, we concluded that forced expression of the three factors Sox10, Olig2 and Zfp536 was the best of the combinations we tested to induce Plp-EGFP + cells from MEFs. A r t i c l e s Generation of iOPCs from rat fibroblasts Given that culture conditions for primary rat OPCs have been extensively characterized and are well-established, we tested whether the combination of Sox10, Olig2 and Zfp536 could convert rat fibroblasts into OPC-like cells (Fig. 2a) . We observed large, proliferative clusters of cells with bipolar, OPC-like morphologies (Fig. 2b) that could be labeled with O4 antibodies 14 d after infection 26, 28 (Fig. 2c) . These O4 + cells proliferated in response to platelet-derived growth factor (PDGF, a known OPC mitogen) as revealed by EdU incorporation (Supplementary Fig. 3 ). We also found some GFAP + astrocytic cells but no Tuj1 + or Map2 + neurons 20 d after infection ( Supplementary  Fig. 4) . After confirming the absence of O4 + cells in control rat fibroblasts ( Supplementary Fig. 5 ), we used established immunopanning methods to purify the rat O4 + cells and used them for further characterizations in the rest of this study. Immunopanned O4 + cells had typical OPC morphologies when placed in media containing PDGF and stained positive for three additional OPC markers, NG2, A2B5 and S100β (Fig. 2d-g ). PCR analysis of genomic DNA from immunopanned O4 + cells confirmed the integration of the three proviruses (Supplementary Fig. 6 ). As the fibroblast-derived O4 + cells proliferated in response to PDGF, exhibited typical morphologies and expressed key markers of OPCs, we called these cells iOPCs. The observed GFAP + cells could indicate the generation of an astrocyterestricted progenitor or the spontaneous differentiation of a bipotent, glial-restricted progenitor. The absence of neurons suggests that no intermediate tripotent neural progenitor cell was induced.
Next we characterized the reprogramming kinetics and efficiencies. As both fibroblasts and iOPCs are proliferative (Fig. 2h) , the true cellconversion efficiency could not be determined. Instead, we assessed the iOPC yield, defined as the ratio of the number of O4-immunopanned cells on day 20 after infection to the number of infected fibroblasts (Online Methods). After seeding and infection of 2.4 × 10 5 fibroblasts/cm 2 , ~25.9 ± 4.9% of the fibroblasts expressed all three factors, and on average 6.8 ± 1.7 × 10 4 O4 + cells/cm 2 could be recovered 20 d after induction, resulting in a reprogramming yield of ~106.7% at this time point (Fig. 2i) . The iOPC purity, defined as the ratio of O4-immunopanned cells to the total number of harvested cells on day 20, was on average 15.6 ± 3.3% (Fig. 2j) . We assume that the yield and purity values are both slight underestimates, considering that cells strongly labeled by O4 antibody were not efficiently dissociated from the O4 antibody-coated panning plate. We note that the yield is a parameter dependent on reprogramming efficiency, cell death and proliferation and therefore the true reprogramming efficiency is almost certainly lower. Indeed, the yield of O4 + cells was substantially lower at earlier time points, when the influence of cell proliferation may have been smaller (Fig. 2h) . Moreover, the yield of functional iOPCs was even lower because the differentiation efficiency of O4 + cells was ~25% that of primary neonatal OPCs (see below).
Global transcriptional remodeling in iOPCs
We next compared the global gene expression patterns of rat iOPCs, fibroblasts, primary OPCs and their differentiated progeny by microarray analysis (Fig. 3) . A heatmap depicting all probe sets that were differentially expressed between any of the samples by at least twofold showed that the transcriptional program characteristic of fibroblasts was globally reprogrammed toward that of the oligodendroglial lineage (Fig. 3a) . Genes upregulated in iOPCs compared to fibroblasts were significantly enriched for GO terms associated with oligodendroglial biology (shown are all GO terms with P <10 −9 ). Conversely, fibroblast genes with significantly enriched GO terms involving mesodermal cell functions were globally downregulated in iOPCs (Fig. 3a) . (Fig. 3a) . The transcription levels of the fibroblast-specific genes Col1a1, Col5a1 and Thy1 were significantly downregulated (Fig. 3a) . We confirmed the expression changes of these genes by quantitative RT-PCR ( Fig. 3c and Supplementary Table 1 ). In agreement with these results, unsupervised hierarchical clustering analysis and Pearson's correlation analysis of the expression values of all differentially expressed genes showed that the transcriptional profile of iOPCs is much more similar to that of primary OPCs (r 2 = 0.42) than to that of fibroblasts (r 2 = 0.15) (Fig. 3b) . Quantitative RT-PCR analysis demonstrated that the mRNA levels of some genes associated with the differentiation of OPCs, such as Cdkn1c, Mbp, Mog and Plp1a, are higher in iOPCs compared to primary OPCs to various degrees but lower than that of mature oligodendrocytes (Fig. 3c) . However, the observed higher transcript levels of these differentiation-associated genes appeared to be insufficient to produce detectable protein as no MBP + , PLP + , CNP + or MOG + cells could be found in iOPC cultures, based on immunofluorescence. In accordance with the quantitative RT-PCR results, Pearsons's correlation analysis showed a higher similarity of iOPCs to early differentiating OPCs than to undifferentiated OPCs (Fig. 3b) . Examination of the overall heatmap (Fig. 3a) also suggested the induction of a set of genes in iOPCs that were not expressed in the oligodendroglial samples. Indeed, 31 probe sets representing 24 genes were found to be upregulated in iOPCs but not in any other samples (Supplementary Table 2) . No coherent function could be assigned to this group of genes (Supplementary Table 3 ).
iOPCs differentiate into myelinating oligodendrocytes To assess the functional properties of iOPCs, we first evaluated the differentiation potential of iOPCs in vitro. Upon PDGF withdrawal the immunopanned O4 + cells stopped dividing and differentiated into cells that expressed MBP and CNPase, and that exhibited mature oligodendrocytic morphologies (Fig. 4a,b) . After 3 weeks of differentiation, 11.6 ± 2.5% of the cells were MBP + . Given that OPCs can give rise to astrocytes in vitro, we also assessed GFAP and Nestin expression in differentiated iOPC cultures. GFAP + (27.6 ± 1.7%) and Nestin + (29.0 ± 5.0%) astrocytic cells were readily observed, however, no Tuj1 + or Map2 + neuronal cells were present (Fig. 4c,d and Supplementary Fig. 4) .
We then evaluated the myelinogenic potential of the iOPCs in vitro using a co-culture system with dorsal root ganglion neurons (DRGs) 29 . Purified DRGs were allowed to extend dense beds of axons before plating O4-immunopanned iOPCs. After 9 d of co-culture, iOPCs gave rise to MBP + cells with complex oligodendrocytic morphology that were in close vicinity to the neurofilament + axons (Fig. 4e) . Many MBP + cells extended multiple distinctive membrane extensions closely aligned with surrounding axons (Fig. 4e,  boxed cell) . In the presence of DRGs, the differentiation efficiency of O4 + iOPCs into MBP + oligodendrocytes slightly increased to 15.5 ± 1.9% (Fig. 4f) . This differentiation efficiency is ~25% of that of rat primary neonatal OPCs (B.Z. and B.A.B., data not shown).
To study the capacity of iOPCs to myelinate host axons in vivo, we transplanted the O4-immunopanned rat iOPCs into the shiverer mouse brains. These mice lack large portions of the Mbp gene and have dysmyelinated axons throughout the central nervous system 30, 31 . Thus, this transplantation model allows for unambiguous detection of graft-derived oligodendrocytes because any MBP signal must be derived from grafted cells. Purified iOPCs were injected bilaterally into the corpus callosum and cerebellum of neonatal mice (n = 3). Doxycycline was added to the drinking water of nursing female mice for 3 weeks, to maintain initial transgene expression, and grafted shiverer mice were euthanized at 12 weeks of age, and their brains were cryosectioned and immunostained for MBP. In all 12 injection sites of the three grafted brains, small scattered groups of MPB + cells forming tube-like structures were detected in the cortex, corpus callosum and white matter tract of the cerebellum (on average, about 90-100 cells per injection site) (Fig. 5a-d) . No similar structures were observed in nontransplanted shiverer brains after MBP staining. All MBP + cells analyzed co-expressed Plp, the transmembrane proteolipid protein that is the predominant myelin protein present in the central but not peripheral nervous system (Fig. 5c,d) . The MBP + 
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A r t i c l e s cells did not express Protein Zero (P0), the major structural protein of peripheral myelin or Peripherin (Fig. 5e,f and Supplementary Fig. 7 ). Confocal microscopy revealed that the MBP + tube-like structures surrounded neurofilament + axons, demonstrating oligodendroglial ensheathment of host axons by the transplanted iOPCs (Fig. 5g,h) . Finally, we confirmed myelin formation of transplanted iOPCs on the ultrastructural level ( Fig. 5i and Supplementary Fig. 8 ). Several lines of evidence suggest that iOPCs are similar but not identical to primary OPCs. Compared to neonatal OPCs, the fibroblast-derived iOPCs have a lower efficiency of differentiation into mature oligodendrocytes and their gene expression profile is similar to, yet still distinct from that of primary OPCs, although the fibroblast-specific transcriptional network programs appear to be effectively downregulated. These transcriptional differences could be explained by several not mutually exclusive reasons. First, the iOPC cultures (as defined by O4 immunoreactivity) could represent a fairly heterogeneous population of fully and partially reprogrammed cells, similar to what was found in the first reports of induced pluripotent stem (iPS) cells [32] [33] [34] . However, whereas the transcriptional profile seems to be more similar to OPCs undergoing differentiation, the elevated mRNA levels of differentiation genes do not result in detectable protein or mature oligodendrocyte morphology, suggesting that they might not be functionally important. In addition, we observed a small group of aberrantly expressed genes unique to iOPCs. These might be direct or indirect targets of the reprogramming factors, which have documented roles in regulating other cell lineages (e.g., Sox10 in neural crest lineages, Olig2 in motor and ventral forebrain neurons). Future studies could address whether these fairly subtle differences may lead to detectable functional consequences.
Notably, we believe it to be highly unlikely that iOPCs were derived from contaminating neural crest stem cells or Schwann cell precursor cells. First, we carefully dissected the tissue before fibroblast generation, minimizing contamination by neural crest progenitor cells. Second, we previously performed an extensive molecular characterization of these primary fibroblast cultures and found no evidence of neural crest or Schwann cell marker expression 14 . Third, we demonstrated that iOPCs differentiate into myelinating cells that are PLP + , a marker that is specific to oligodendrocytes, and P0 -, a specific marker of Schwann cells. Finally, we found that multiple host axons can be ensheathed by single engrafted cells, which is a typical feature of oligodendrocytes, whereas Schwann cells can only myelinate one axon per cell.
Given the strong clinical interest in OPCs for regenerative therapies, one of the most important next steps is to translate our findings to human fibroblasts. Based on our experience with iPS and iN cells, we predict that generation of human iOPCs is possible but may require additional reprogramming factors, such as other transcriptional regulators or microRNAs 15, [35] [36] [37] . Substantial optimization will likely be required to reliably generate large numbers of iOPCs from human cells that are functionally indistinguishable from OPCs of the human brain.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession code. The complete microarray data set, GEO: GSE40421. 
